Use of Axillary Ultrasound to Guide Breast Cancer Management in the Genomic Assay Era

KK Women's and Children's Hospital

Status: Active, not recruiting

Conditions: Axillary Ultrasound

Treatments: Diagnostic Test: axillary ultrasound

Study type: Observational

Funder types: Other

Identifiers

NCT06038110

CIRB Ref:2022/2514

Details and patient eligibility

About

The investigators aimed to determine if axillary ultrasound can reliably distinguish between patients with limited or high nodal burden, so that the patients with limited nodal burden can potentially avoid chemotherapy and instead receive upfront surgery followed by gene assay testing.

Enrollment: 150 estimated patients

Sex: Female

Ages: 21 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• breast cancer patients with T1-3, HR-positive and HER2-negative disease.
• aged≥ 50 years old
• had axillary ultrasound prior to operation
• axillary lymph node dissection

Exclusion criteria

• Patients with neoadjuvant chemotherapy
• bilateral cancers